NS · Pharmaceuticals

Cipla Ltd (CIPLA)

Pharmaceuticals & Biotechnology

Cipla Ltd (CIPLA) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-11, reported market cap is $1.16T, P/E ratio is 32.97, net margin is 22.1%, dividend yield is 0.91%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for CIPLA

Market cap

$1.16T

P/E ratio

32.97

Net margin

22.1%

Dividend yield

0.91%

Cipla Ltd (CIPLA) — FAQ

What is Cipla Ltd's market cap?

Cipla Ltd (CIPLA) has a reported market cap of $1.16T (data as of 2026-07-11).

What is CIPLA's P/E ratio?

The price-to-earnings (P/E) ratio for Cipla Ltd (CIPLA) is 32.97 (data as of 2026-07-11).

Does Cipla Ltd pay a dividend?

Cipla Ltd (CIPLA) shows a reported dividend yield of 0.91%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-11).

What sector is Cipla Ltd in?

Cipla Ltd (CIPLA) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).

What exchange is CIPLA listed on?

CIPLA is listed on NS.

What is Cipla Ltd's net margin?

Cipla Ltd (CIPLA) reports a net margin of 22.1% (data as of 2026-07-11).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Pharmaceuticals companies

FDC Ltd (FDC) Strides Pharma Science Ltd (STAR)